US Stock MarketDetailed Quotes

SCPH scPharmaceuticals

Watchlist
  • 3.620
  • -0.120-3.21%
Close Nov 29 13:00 ET
  • 3.650
  • +0.030+0.83%
Post 17:01 ET
181.15MMarket Cap-1856P/E (TTM)

scPharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

scPharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
10.80M
10.03M
-774.67K
Miss Est.
+184.53%
+164.12%
-7.17%
EPS
-0.30
-0.75
-0.45
Miss Est.
+27.25%
-82.93%
-151.51%
Analyst Rating
Strong Buy

Nov 30, 2024

scPharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 14.433M--
--2024/Q4-- / 12.203M--
Nov 13, 20242024/Q310.026M / 10.801M--
Aug 14, 20242024/Q28.054M / 7.970M--
May 14, 20242024/Q16.102M / 5.977M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 14.433M--
--2024/Q4-- / 12.203M--
Nov 13, 20242024/Q310.026M / 10.801M--
Aug 14, 20242024/Q28.054M / 7.970M--
May 14, 20242024/Q16.102M / 5.977M--

Unlock Free Earnings Estimates

scPharmaceuticals Earnings Reports

  • scPharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 13 17:18 ET

  • scPharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:11 ET

  • scPharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 14 16:26 ET

  • scPharmaceuticals | 10-K: FY2023 Annual Report

    Mar 13 16:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data